Phase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study).

Trial Profile

Phase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study).

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Cariprazine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top